BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9188616)

  • 1. Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.
    Shafer RW; Eisen JA; Merigan TC; Katzenstein DA
    J Virol; 1997 Jul; 71(7):5441-8. PubMed ID: 9188616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pol gene diversity of five human immunodeficiency virus type 1 subtypes: evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D.
    Cornelissen M; van den Burg R; Zorgdrager F; Lukashov V; Goudsmit J
    J Virol; 1997 Sep; 71(9):6348-58. PubMed ID: 9261352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance.
    Loemba H; Brenner B; Parniak MA; Ma'ayan S; Spira B; Moisi D; Oliveira M; Detorio M; Essex M; Wainberg MA
    Antiviral Res; 2002 Nov; 56(2):129-42. PubMed ID: 12367719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
    Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA
    AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies.
    Sato H; Tomita Y; Shibamura K; Shiino T; Miyakuni T; Takebe Y
    J Virol; 2000 Jun; 74(11):5357-62. PubMed ID: 10799614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.
    Apetrei C; Descamps D; Collin G; Loussert-Ajaka I; Damond F; Duca M; Simon F; Brun-Vézinet F
    J Virol; 1998 May; 72(5):3534-8. PubMed ID: 9557632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary subtype C HIV-1 infection in Harare, Zimbabwe.
    Tien PC; Chiu T; Latif A; Ray S; Batra M; Contag CH; Zejena L; Mbizvo M; Delwart EL; Mullins JI; Katzenstein DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):147-53. PubMed ID: 10048901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants.
    Yerly S; Rakik A; De Loes SK; Hirschel B; Descamps D; Brun-Vézinet F; Perrin L
    J Virol; 1998 May; 72(5):3520-3. PubMed ID: 9557630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.
    Loemba H; Brenner B; Parniak MA; Ma'ayan S; Spira B; Moisi D; Oliveira M; Detorio M; Wainberg MA
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2087-94. PubMed ID: 12069959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.
    Quiñones-Mateu ME; Albright JL; Mas A; Soriano V; Arts EJ
    J Virol; 1998 Nov; 72(11):9002-15. PubMed ID: 9765445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
    Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
    Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates.
    Palmer S; Alaeus A; Albert J; Cox S
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):157-62. PubMed ID: 9462926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
    Miranda LR; Götte M; Liang F; Kuritzkes DR
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2648-56. PubMed ID: 15980332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus 1 strains resistant to nucleoside inhibitors of reverse transcriptase in isolates from the Czech Republic as monitored by line probe assay and nucleotide sequencing.
    Reinis M; Vandasová J; Stanková M; Linka M; Brůcková M
    Acta Virol; 2001; 45(5-6):279-86. PubMed ID: 12083326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.
    Bruce C; Clegg C; Featherstone A; Smith J; Biryahawaho B; Downing R; Oram J
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1543-50. PubMed ID: 7888209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.
    Kantor R; Zijenah LS; Shafer RW; Mutetwa S; Johnston E; Lloyd R; von Lieven A; Israelski D; Katzenstein DA
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1407-13. PubMed ID: 12512512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 pol sequences from India fit distinct subtype pattern.
    Soto-Ramirez LE; Tripathy S; Renjifo B; Essex M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(4):299-307. PubMed ID: 8948366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic and phenotypic changes during culture of a multinucleoside-resistant human immunodeficiency virus type 1 strain in the presence and absence of additional reverse transcriptase inhibitors.
    Shafer RW; Winters MA; Iversen AK; Merigan TC
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2887-90. PubMed ID: 9124861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence diversity of the reverse transcriptase of human immunodeficiency virus type 1 from untreated Brazilian individuals.
    Brindeiro R; Vanderborght B; Caride E; Correa L; Oravec RM; Berro O; Stuyver L; Tanuri A
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1674-80. PubMed ID: 10390221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.